HUT74452A - Preparation for substitution therapy, containing at least one progestogen and at least one extrogen - Google Patents

Preparation for substitution therapy, containing at least one progestogen and at least one extrogen

Info

Publication number
HUT74452A
HUT74452A HU9600592A HU9600592A HUT74452A HU T74452 A HUT74452 A HU T74452A HU 9600592 A HU9600592 A HU 9600592A HU 9600592 A HU9600592 A HU 9600592A HU T74452 A HUT74452 A HU T74452A
Authority
HU
Hungary
Prior art keywords
progestogen
pct
preparation
estrogen
substitution therapy
Prior art date
Application number
HU9600592A
Other languages
English (en)
Other versions
HU224818B1 (en
HU9600592D0 (en
Inventor
Philippe Robert Marie Koninckx
Original Assignee
Saturnus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saturnus Ag filed Critical Saturnus Ag
Publication of HU9600592D0 publication Critical patent/HU9600592D0/hu
Publication of HUT74452A publication Critical patent/HUT74452A/hu
Publication of HU224818B1 publication Critical patent/HU224818B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HU9600592A 1993-09-09 1994-09-08 The use of progestogen and estrogen for manufacturing a pharmaceutical composition for substitution therapy and oral contraception HU224818B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9301562A NL9301562A (nl) 1993-09-09 1993-09-09 Preparaat voor substitutietherapie.
PCT/EP1994/002997 WO1995007081A1 (en) 1993-09-09 1994-09-08 Preparation for substitution therapy, containing at least one progestogen and at least one extrogen

Publications (3)

Publication Number Publication Date
HU9600592D0 HU9600592D0 (en) 1996-05-28
HUT74452A true HUT74452A (en) 1996-12-30
HU224818B1 HU224818B1 (en) 2006-02-28

Family

ID=19862861

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600592A HU224818B1 (en) 1993-09-09 1994-09-08 The use of progestogen and estrogen for manufacturing a pharmaceutical composition for substitution therapy and oral contraception

Country Status (12)

Country Link
US (1) US5827843A (hu)
EP (1) EP0717626B1 (hu)
JP (1) JPH09502194A (hu)
KR (1) KR960704553A (hu)
CN (1) CN1076969C (hu)
AT (1) ATE241362T1 (hu)
AU (1) AU708881B2 (hu)
DE (1) DE69432752T2 (hu)
FI (1) FI961098A (hu)
HU (1) HU224818B1 (hu)
NL (1) NL9301562A (hu)
WO (1) WO1995007081A1 (hu)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
US6506390B2 (en) 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
ES2229378T3 (es) * 1996-07-26 2005-04-16 Wyeth Anticonceptivo oral.
WO1998004246A2 (en) * 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
PL201878B1 (pl) * 2000-01-18 2009-05-29 Bayer Schering Pharma Ag Kompozycja farmaceutyczna w doustnej postaci dawkowania. zawierająca estrogen i drospirenon, zastosowanie kompozycji i preparat farmaceutyczny
HRP20020666B1 (en) * 2000-01-18 2011-07-31 Bayer Schering Pharma Aktiengesellschaft Drospirenone for hormone replacement therapy
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
EP1857110A3 (en) * 2001-03-16 2008-08-06 Wyeth Hormone replacement therapy
IL157944A0 (en) * 2001-03-16 2004-03-28 Wyeth Corp Hormone replacement therapy
WO2002092102A2 (en) 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
EP1260225A1 (en) * 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
US8048869B2 (en) * 2001-05-18 2011-11-01 Pantarhei Bioscience B.V. Pharmaceutical composition for use in hormone replacement therapy
ATE449606T1 (de) * 2001-05-23 2009-12-15 Pantarhei Bioscience Bv Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
PT1390042E (pt) * 2001-05-23 2008-03-10 Pantarhei Bioscience Bv Sistema de administração de um medicamento que compreende estrogénio tetrahidroxilado destinado à contracepção hormonal
WO2003006027A1 (en) * 2001-07-13 2003-01-23 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
WO2003018026A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
WO2003041718A1 (en) * 2001-11-15 2003-05-22 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
PT1453521E (pt) 2001-12-05 2013-10-08 Teva Womens Health Inc Contracetivos orais para prevenir a gravidez e diminuir a sintomatologia pré-menstrual
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200306846A (en) * 2002-04-03 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
US7923440B2 (en) * 2002-06-11 2011-04-12 Pantarhei Bioscience B.V. Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
US7943604B2 (en) * 2002-06-11 2011-05-17 Pantarhei Bioscience B.V. Method of treating human skin and a skin care composition for use in such a method
AU2003253506A1 (en) 2002-07-12 2004-02-02 Pantarhei Biosciences B.V. Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
SI1556058T1 (sl) * 2002-10-23 2008-02-29 Pantarhei Bioscience Bv Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
CA2674325A1 (en) * 2007-01-08 2008-07-17 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
ITMI20122027A1 (it) * 2012-11-28 2014-05-29 Altergon Sa Soluzioni acquose orali di ormoni steroidei e hp¿cd con biodisponibilità ottimizzata

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
NO301689B1 (no) * 1987-09-24 1997-12-01 Jencap Research Ltd Kontraseptivt preparat i form av en forpakning
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product

Also Published As

Publication number Publication date
JPH09502194A (ja) 1997-03-04
AU708881B2 (en) 1999-08-12
EP0717626B1 (en) 2003-05-28
US5827843A (en) 1998-10-27
KR960704553A (ko) 1996-10-09
ATE241362T1 (de) 2003-06-15
AU7695294A (en) 1995-03-27
HU224818B1 (en) 2006-02-28
WO1995007081A1 (en) 1995-03-16
HU9600592D0 (en) 1996-05-28
CN1133011A (zh) 1996-10-09
NL9301562A (nl) 1995-04-03
FI961098A (fi) 1996-04-03
FI961098A0 (fi) 1996-03-08
CN1076969C (zh) 2002-01-02
DE69432752T2 (de) 2004-04-08
DE69432752D1 (de) 2003-07-03
EP0717626A1 (en) 1996-06-26

Similar Documents

Publication Publication Date Title
HUT74452A (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
AU609664B1 (en) A method of treating premature ejaculation using sertraline
MX9802130A (es) Agonistas adrenergicos beta3 selectivos.
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
GR3022510T3 (en) Lyospheres comprising gonadotropin
IL110045A (en) Pharmaceutical compositions containing oligopeptides for combating AIDS and ARC and for immune stimulation and certain such novel oligopeptides
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
AU7496894A (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
GR3024157T3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
AU1191795A (en) Deuterated active substances in transdermal application
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
HUT77868A (hu) Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
IL109866A (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
AU7941294A (en) Composition for the treatment or prevention of herpes
CA2171460A1 (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
IL110289A0 (en) Pharmaceutical compositions comprising 4'-iodo-4'- deoxydoxorubicin for treating amyloidosis
MX9706188A (es) Inhibicion de la angiogenesis usando interleucina 12.
IL108283A0 (en) Use of riluzole for promoting restoration following radiation
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь
UA10249A (uk) Спосіб лікування діабетичних ангіопатій
UA28644A (uk) Спосіб лікування первинної аменореї центрального генезу у дівчат-підлітків
UA42427A (uk) Спосіб корекції целюліту та/або локальних жирових відкладень
UA10754A (uk) Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу
MX9802097A (es) Agonistas adrenergicos beta3 selectivos.

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees